Formidable Asset Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Formidable Asset Management’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,736	Closed	-$223K	–	386
2024 Q3	$223K	Sell	1,736 -150	-8%	-$19.6K	0.04%	334
2024 Q2	$214K	Sell	1,886 -172	-8%	-$18.4K	0.03%	361
2024 Q1	$273K	Buy	+2,058	New	+$269K	0.04%	296
2023 Q4	–	Sell	-2,012	Closed	-$153K	–	298
2023 Q3	$153K	Buy	2,012 +300	+18%	+$30.8K	0.03%	269
2023 Q2	$203K	Buy	1,712 +245	+17%	+$30.5K	0.04%	263
2023 Q1	$145K	Buy	1,467 +203	+16%	+$27.5K	0.03%	285
2022 Q4	$179K	Buy	1,264 +63	+5%	+$8.79K	0.04%	281
2022 Q3	$176K	Sell	1,201 -85	-7%	-$15.6K	0.04%	272
2022 Q2	$227K	Buy	1,286 +744	+137%	+$127K	0.05%	261
2022 Q1	$170K	Buy	+542	New	+$204K	0.03%	310

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Formidable Asset Management's LABU Position: Q4 2024 in Review

Formidable Asset Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2024, closing a stake of 1,736 shares — an estimated $223K sold.

Formidable Asset Management first reported a position in LABU in Q1 2022 and held it in 10 quarters. The position peaked at $273K in Q1 2024. 37 funds tracked by Wall St. Rank hold LABU as of Q4 2024.

Formidable Asset Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
Formidable Asset Management sold 1,736 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2024, an estimated $223K.
Formidable Asset Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2022 and held it in 10 quarters.
Formidable Asset Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $273K in Q1 2024.
37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2024.

Based on Formidable Asset Management's 13F filing for Q4 2024, filed 19 Feb 2025.